CompletedNot Applicable

Mellowing Mind: Comparing Two Technology Based Mindfulness Interventions for Stress Impacted by COVID-19 in Underserved Communities

United States270 participantsStarted 2021-05-14

Plain-language summary

The purpose of this study is to examine the comparative effectiveness of two technology-based Mindfulness Based Stress Reduction (MBSR) programs (one via video/teleconference and one via a smartphone app) for reducing worry, anxiety and/or related mental health effects of stress in members of identified underserved communities, which were highly impacted by the COVID-19 pandemic.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years and older * Significant worry as per the Penn State Worry Questionnaire-Abbreviated \[PSWQ-A\] * Fluent in English * Reside in one of the local city zip codes, identified as underserved, and primarily African American, communities Exclusion Criteria: * Severe depression as per Patient Health Questionnaire \[PHQ-9\] * Active suicidal intent as per PHQ-9 question 9 * Diagnosis of psychosis, or bipolar disorder, or moderate or severe substance use disorder in the past month as per self report * Cognitive impairment as per (modified) Short Portable Mental Status Questionnaire \[SPMSQ\] * Currently receiving psychotherapy or behavioral counseling, including MBSR * Change in psychotropic medications within the last month as per self report * Unable to communicate in a way that would allow for participation in screenings or sessions

What they're measuring

Changes in Worry from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention

Timeframe: 21 Weeks: Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention

Trial details

NCT IDNCT05180513

SponsorState University of New York at Buffalo

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More Worry trials